Sellas Life Sciences Group Inc (SLS.OQ)
SLS.OQ on NASDAQ Stock Exchange Capital Market
1.75USD
5:04pm BST
1.75USD
5:04pm BST
Change (% chg)
$-0.27 (-13.37%)
$-0.27 (-13.37%)
Prev Close
$2.02
$2.02
Open
$1.85
$1.85
Day's High
$1.93
$1.93
Day's Low
$1.65
$1.65
Volume
417,482
417,482
Avg. Vol
146,504
146,504
52-wk High
$11.82
$11.82
52-wk Low
$0.80
$0.80
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Angelos Stergiou |
2017 | President, Chief Executive Officer, Director | |
Gene Mack |
2018 | Chief Financial Officer, Treasurer | |
Nicholas Sarlis |
2017 | Chief Medical Officer, Senior Vice President | |
John Burns |
2017 | Vice President - Finance, Corporate Controller | |
David Scheinberg |
2017 | Director |
- BRIEF-Sellas Life Sciences Files For Offering Of Up To $30 Mln
- BRIEF-Sellas Life Sciences Receives FDA Orphan Drug Designation For Galinpepimut-S For Treatment Of Multiple Myeloma
- BRIEF-Sellas Life Sciences Ceases Gregory Torre's Employment As Chief Regulatory Officer
- BRIEF-Sellas Life Sciences Announces Appointment Of Gene Mack As Chief Financial Officer & Treasurer